P135 Efficacy and safety of nerandomilast in patients with autoimmune disease-related progressive pulmonary fibrosis: subgroup analysis of the FIBRONEER-ILD trial

P135 Efficacy and safety of nerandomilast in patients with autoimmune disease-related progressive pulmonary fibrosis: subgroup analysis of the FIBRONEER-ILD trial | ReachRx